5 Trials Link GLP-1 Drugs to Better Male Fertility in Obese Men
Updated
Updated · Fox News · Jun 20
5 Trials Link GLP-1 Drugs to Better Male Fertility in Obese Men
3 articles · Updated · Fox News · Jun 20
Summary
Research presented at ENDO 2026 found GLP-1 weight-loss drugs may improve testosterone, sperm quality and metabolic health in obese men with low testosterone tied to obesity.
Five randomized controlled trials in men aged 18 to 65 suggested the drugs do not acutely suppress the hormone axis that regulates testosterone and sperm production, easing a key safety concern.
A 16-week liraglutide trial improved hormones in men with functional hypogonadism, another liraglutide study reported higher sperm concentration and count, and a 24-week semaglutide trial improved sperm shape while preserving testosterone.
Researchers said the evidence base remains small and heterogeneous, with only five trials, and called for larger studies specifically designed to measure male reproductive outcomes.
The findings add to growing interest in GLP-1s beyond weight loss, with outside experts saying they could eventually offer obese men a fertility-preserving alternative to testosterone replacement therapy.
As GLP-1s show promise for male fertility, what are the unknown long-term risks for fathers and their future children?
Is Ozempic the future for male infertility, or an expensive shortcut that overlooks proven lifestyle changes?
GLP-1 Drugs Show Early Promise for Male Fertility: New Evidence from ENDO 2026 Highlights Testosterone and Sperm Quality Gains in Obese Men
Overview
Obesity in men often leads to fertility problems by disrupting the hypothalamic-pituitary-gonadal (HPG) axis, which causes low testosterone and poor semen quality, making it harder for obese men to conceive. New research presented at ENDO 2026 highlights that GLP-1 receptor agonists, commonly used for weight loss and diabetes, may help improve testosterone levels and sperm quality in these men. This promising effect challenges the traditional approach of treating low testosterone with hormone therapy alone, suggesting that GLP-1 drugs could offer a new way to address both metabolic health and fertility issues together.